BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17112774)

  • 1. Epidermal growth factor receptor (EGFR) polymorphisms and survival in head and neck cancer patients.
    Bandrés E; Barricarte R; Cantero C; Honorato B; Malumbres R; Zárate R; Alcalde J; García-Foncillas J
    Oral Oncol; 2007 Aug; 43(7):713-9. PubMed ID: 17112774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T; Yuza Y; Saito Y; O-uchi J; Kondo S; Okabe M; Yamada H; Kato T; Moriyama H; Kurihara S; Urashima M
    Oncologist; 2009 Sep; 14(9):900-8. PubMed ID: 19726454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidermal growth factor receptor gene polymorphisms predict pelvic recurrence in patients with rectal cancer treated with chemoradiation.
    Zhang W; Park DJ; Lu B; Yang DY; Gordon M; Groshen S; Yun J; Press OA; Vallböhmer D; Rhodes K; Lenz HJ
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):600-5. PubMed ID: 15701846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer.
    Temam S; Kawaguchi H; El-Naggar AK; Jelinek J; Tang H; Liu DD; Lang W; Issa JP; Lee JJ; Mao L
    J Clin Oncol; 2007 Jun; 25(16):2164-70. PubMed ID: 17538160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of the epidermal growth factor receptor (EGFR) and survival in patients with advanced cancer of the head and neck (HNSCC).
    Stoehlmacher-Williams J; Obermann L; Ehninger G; Goekkurt E
    Anticancer Res; 2012 Feb; 32(2):421-5. PubMed ID: 22287728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender-related survival differences associated with EGFR polymorphisms in metastatic colon cancer.
    Press OA; Zhang W; Gordon MA; Yang D; Lurje G; Iqbal S; El-Khoueiry A; Lenz HJ
    Cancer Res; 2008 Apr; 68(8):3037-42. PubMed ID: 18413774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of expression of Ki-67, EGFR, c-erbB-2, MMP-9, p53, bcl-2, CD34 and cell cycle analysis with survival in head and neck squamous cell cancer.
    Smilek P; Dusek L; Veselý K; Rottenberg J; Kostrica R
    J Exp Clin Cancer Res; 2006 Dec; 25(4):549-55. PubMed ID: 17310847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor gene polymorphisms, R497K, but not (CA)n repeat, is associated with dilated cardiomyopathy.
    Zhou B; Rao L; Peng Y; Zhang Q; Zhang L
    Clin Chim Acta; 2009 May; 403(1-2):184-7. PubMed ID: 19265688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermal growth factor receptor R497K polymorphism is a favorable prognostic factor for patients with colorectal carcinoma.
    Wang WS; Chen PM; Chiou TJ; Liu JH; Lin JK; Lin TC; Wang HS; Su Y
    Clin Cancer Res; 2007 Jun; 13(12):3597-604. PubMed ID: 17575224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel C/T polymorphism in the core promoter of human de novo cytosine DNA methyltransferase 3B6 is associated with prognosis in head and neck cancer.
    Wang L; Rodriguez M; Kim ES; Xu Y; Bekele N; El-Naggar AK; Hong WK; Mao L; Oh YW
    Int J Oncol; 2004 Oct; 25(4):993-9. PubMed ID: 15375549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No association between epidermal growth factor and epidermal growth factor receptor polymorphisms and nasopharyngeal carcinoma.
    Gao LB; Wei YS; Zhou B; Wang YY; Liang WB; Li C; Li Y; Bai P; Fang WL; Xue H; Zhang L
    Cancer Genet Cytogenet; 2008 Sep; 185(2):69-73. PubMed ID: 18722874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between transforming growth factor beta1 genetic polymorphism and response to chemoradiotherapy in head and neck squamous cell cancer.
    Lundberg M; Pajusto M; Koskinen WJ; Mäkitie AA; Aaltonen LM; Mattila PS
    Head Neck; 2009 May; 31(5):664-72. PubMed ID: 19260117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
    Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and mutation analysis of her2 in head and neck squamous cell carcinoma.
    Ali MA; Gunduz M; Gunduz E; Tamamura R; Beder LB; Katase N; Hatipoglu OF; Fukushima K; Yamanaka N; Shimizu K; Nagatsuka H
    Cancer Invest; 2010 Jun; 28(5):495-500. PubMed ID: 20014947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck squamous cell carcinoma is not associated with interleukin-18 promoter gene polymorphisms: a case-control study.
    Asefi V; Mojtahedi Z; Khademi B; Naeimi S; Ghaderi A
    J Laryngol Otol; 2009 Apr; 123(4):444-8. PubMed ID: 18940019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor beta 1 genotype and p16 as prognostic factors in head and neck squamous cell carcinoma.
    Lundberg M; Leivo I; Saarilahti K; Mäkitie AA; Mattila PS
    Acta Otolaryngol; 2012 Sep; 132(9):1006-12. PubMed ID: 22667340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.
    Werbrouck J; De Ruyck K; Duprez F; Van Eijkeren M; Rietzschel E; Bekaert S; Vral A; De Neve W; Thierens H
    Mutat Res; 2008 Oct; 656(1-2):74-81. PubMed ID: 18768166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EGFR mutations and human papillomavirus in squamous cell carcinoma of tongue and tonsil.
    Na II; Kang HJ; Cho SY; Koh JS; Lee JK; Lee BC; Lee GH; Lee YS; Yoo HJ; Ryoo BY; Yang SH; Shim YS
    Eur J Cancer; 2007 Feb; 43(3):520-6. PubMed ID: 17224267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of TESTIN and its association with cancer history and a tendency toward poor survival in head and neck squamous cell carcinoma.
    Gunduz E; Gunduz M; Beder L; Nagatsuka H; Fukushima K; Sutcu R; Delibas N; Yamanaka N; Shimizu K; Nagai N
    Arch Otolaryngol Head Neck Surg; 2009 Mar; 135(3):254-60. PubMed ID: 19289703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to chemoradiation in rectal cancer by a gene polymorphism in the epidermal growth factor receptor promoter region.
    Spindler KL; Nielsen JN; Lindebjerg J; Brandslund I; Jakobsen A
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):500-4. PubMed ID: 16757132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.